Article Text

Download PDFPDF
Short report
Implications of the EU Directive on prevention from sharp injuries in the hospital and healthcare sector on procurement decisions

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding Sanofi UK provided an educational grant to support the expert consensus group consisting of Dr Debra Adams, Programme Specialist, Healthcare Associated Infection, NHS Midlands and East; Dr Duncan McRobbie, Associate Chief Pharmacist and Clinical Governance Pharmacist, Guy's and St Thomas' NHS Trust; Professor Malcolm Partridge, Director of Pharmacy, Nottingham NHS Trust; Mr Mark Santillo (Chair), Regional QA Pharmacist, South West; Mr Inderjit Singh, Associate Director of Commercial Pharmacy Services, University Hospitals Birmingham NHS Trust; Ms Kim Sunley, Senior Employment Relations Advisor, Royal College of Nursing. This consensus panel meeting informed this document. Note that Sanofi did not participate in the consensus panel and did not have input into or sight of the document.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.